WebNovo Nordisk announces completion of Dicerna Pharmaceuticals acquisition. Bagsværd, Denmark, 28 December 2024 – Novo Nordisk today announced that the acquisition of … WebDec 25, 2024 · Dicerna Pharmaceuticals, Inc. DRNA is a biopharmaceutical company focused on discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi ...
Novo Nordisk $3.3 billion acquisition of Dicerna Pharmaceuticals
WebNov 18, 2024 · Davis Polk is advising Novo Nordisk on its approximately $3.3 billion acquisition of Dicerna Pharmaceuticals, Inc. Under the terms of the acquisition agreement, Novo Nordisk will initiate a tender offer to acquire all outstanding shares of Dicerna. The closing of the tender offer will be subject... WebDec 25, 2024 · dicerna’s stockholders and other investors are urged to read the tender offer materials (including an offer to purchase, a related letter of transmittal and certain … fixed wing flight helmets
News Details - Novo Nordisk
WebThis Dicerna Pharmaceuticals, Inc. Third Amended and Restated 2007 Employee, Director and Consultant Stock Plan was duly adopted by the Board of Directors and stockholders of Dicerna Pharmaceuticals, Inc. (the “Company”) on July 8, 2008, and amends, restates and supersedes in its entirety the Dicerna Pharmaceuticals, Inc. http://dicerna.com/wp-content/uploads/2024/04/Novo-Nordisk-Announces-Completion-of-Dicerna-Pharmaceuticals-Acquisition.pdf WebNovo Nordisk A/S Novo Alle 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790 Our medicines are for the approved indication for which they are authorised in the local country or region. can milk cause weight gain